Published in J Virol on August 01, 1990
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol (1992) 5.30
Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol (1994) 4.40
Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1994) 4.28
Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20
Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J Virol (1999) 3.13
Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol (1992) 2.91
Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol (1992) 2.70
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol (1992) 2.51
Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J Virol (1993) 2.42
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol (1994) 2.21
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J Virol (1998) 2.18
Mammalian reoviruses contain a myristoylated structural protein. J Virol (1991) 2.09
Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol (2007) 1.27
Functional exchange of an oncoretrovirus and a lentivirus matrix protein. J Virol (1994) 1.07
Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins. Virology (2006) 0.86
Single vector system for efficient N-myristoylation of recombinant proteins in E. coli. PLoS One (2010) 0.85
Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association. J Biol Chem (2013) 0.85
Identification, purification and characterization of a membrane-associated N-myristoyltransferase inhibitor protein from bovine brain. Biochem J (1993) 0.81
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 12.54
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell (1989) 9.68
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology (1987) 7.92
Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A (1986) 7.02
High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell (1978) 5.72
Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol (1987) 5.68
Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (1987) 5.26
Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification. Proc Natl Acad Sci U S A (1983) 5.12
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology (1985) 4.65
Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J Virol (1989) 4.60
An evaluation of confocal versus conventional imaging of biological structures by fluorescence light microscopy. J Cell Biol (1987) 4.59
n-Tetradecanoyl is the NH2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc Natl Acad Sci U S A (1982) 4.51
In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid. J Virol (1983) 4.09
High mutation rate of a spleen necrosis virus-based retrovirus vector. Mol Cell Biol (1986) 3.57
Assembly of type C oncornaviruses: a model. Science (1978) 3.53
Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett (1982) 3.42
Identification of retrovirus matrix proteins by lipid-protein cross-linking. J Mol Biol (1979) 3.21
Acylation of proteins with myristic acid occurs cotranslationally. Science (1987) 3.08
High-efficiency ligation and recombination of DNA fragments by vertebrate cells. Science (1983) 2.99
Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol Cell Biol (1984) 2.98
Fatty acylation of proteins. Annu Rev Cell Biol (1988) 2.92
Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol (1989) 2.90
A single N-linked oligosaccharide at either of the two normal sites is sufficient for transport of vesicular stomatitis virus G protein to the cell surface. Mol Cell Biol (1985) 2.78
Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly. J Mol Biol (1984) 2.75
Specificity of fatty acid acylation of cellular proteins. J Biol Chem (1985) 2.63
Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J (1989) 2.24
Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand ("immature") to a collapsed ("mature") form of the virus core. Proc Natl Acad Sci U S A (1977) 2.22
Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J Virol (1986) 2.18
Spontaneous changes in nucleotide sequence in proviruses of spleen necrosis virus, an avian retrovirus. Proc Natl Acad Sci U S A (1982) 2.16
Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci U S A (1987) 2.12
Dependence of Moloney murine leukemia virus production on cell growth. Virology (1975) 2.04
A new group of oncogenic viruses: reticuloendotheliosis, chick syncytial, duck infectious anemia, and spleen necrosis viruses. J Natl Cancer Inst (1973) 2.03
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83
A nucleotide substitution in the gag N terminus of the endogenous ecotropic DBA/2 virus prevents Pr65gag myristylation and virus replication. J Virol (1988) 1.72
Fatty acylation of cellular proteins. Temporal and subcellular differences between palmitate and myristate acylation. J Biol Chem (1986) 1.65
Protein fatty acid acylation: enzymatic synthesis of an N-myristoylglycyl peptide. Proc Natl Acad Sci U S A (1986) 1.60
Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc Natl Acad Sci U S A (1989) 1.47
Membrane properties of the gag gene-coded p15 protein of mouse type-C RNA tumor viruses. J Biol Chem (1978) 1.42
Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector. Mol Cell Biol (1984) 1.42
Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol (1990) 1.42
Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. Proc Natl Acad Sci U S A (1988) 1.38
The relative hydrophobicity of oncornaviral structural proteins. Virology (1978) 1.38
Heteroatom-substituted fatty acid analogs as substrates for N-myristoyltransferase: an approach for studying both the enzymology and function of protein acylation. Proc Natl Acad Sci U S A (1988) 1.37
RNA tumor viruses. Terminology and ultrastructural aspects of virion morphology and replication. J Natl Cancer Inst (1972) 1.35
Electron microscopy of mammalian type-C RNA viruses: use of conditional lethal mutants in studies on virion maturation and assembly. Virology (1976) 1.15
Formation of an infectious virus-antibody complex with Rous sarcoma virus and antibodies directed against the major virus glycoprotein. J Virol (1976) 1.02
Comparative ultrastructural study of four reticuloendothelias viruses. J Virol (1975) 1.01
Comparative morphology of avian and murine leukemia viruses. J Natl Cancer Inst (1971) 0.86
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol (1996) 3.91
Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell (1984) 3.45
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci U S A (1992) 3.01
Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol (1992) 2.70
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J Virol (1993) 2.17
Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J Virol (1997) 2.15
Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J Virol (1997) 1.98
Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83
Oxidation of methane in the absence of oxygen in lake water samples. Appl Environ Microbiol (1979) 1.70
Retroviral DNA integration. Cell (1985) 1.63
Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle. J Virol (2004) 1.57
Ultrastructure of HIV-1 genomic RNA. Virology (1997) 1.49
Cell type-dependence for Vpu function. J Med Primatol (1994) 1.47
Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol (1990) 1.42
Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc Natl Acad Sci U S A (2008) 1.39
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 1.32
The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. J Virol (2005) 1.30
Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J Virol (1993) 1.29
Hantavirus N protein exhibits genus-specific recognition of the viral RNA panhandle. J Virol (2006) 1.28
Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses. J Virol (1992) 1.24
Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo. J Virol (1997) 1.23
Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions. J Virol (2001) 1.16
Bacillus subtilis RNAase III cleavage sites in phage SP82 early mRNA. Cell (1983) 1.13
HIV-1 particle release mediated by Vpu is distinct from that mediated by p6. Virology (1996) 1.12
Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. J Virol (2006) 1.10
Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation. AIDS Res Hum Retroviruses (1992) 1.10
Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function. J Virol (1993) 1.07
Purification and properties of a new bacillus subtilis RNA processing enzyme. Cleavage of phage SP82 mRNA and Bacillus subtilis precursor rRNA. J Biol Chem (1983) 1.03
Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology (1997) 1.00
Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication. J Virol (1997) 0.99
Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein. Virology (2001) 0.95
Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function. AIDS Res Hum Retroviruses (1992) 0.95
The spleen necrosis virus int gene product expressed in Escherichia coli has DNA binding activity and mediates att and U5-specific DNA multimer formation in vitro. Virology (1987) 0.91
The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release. Virology (1997) 0.90
Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant. J Virol (1995) 0.89
Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum Gene Ther (1992) 0.87
The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. J Virol (1993) 0.85
Analysis of bacteriophage SP82 major "early" in vitro transcripts. J Virol (1981) 0.85
Propagation of SIV vectors by genetic complementation with a heterologous env gene. AIDS Res Hum Retroviruses (1992) 0.84
Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA. J Med Primatol (2013) 0.84
Simian immunodeficiency virus vectors: replication and pseudotyping. J Med Primatol (1992) 0.83
The matrix region is responsible for the differential ability of two retroviruses to function as helpers for vector propagation. Virology (1993) 0.83
N-linked glycosylation and reticuloendotheliosis retrovirus envelope glycoprotein function. Virology (1990) 0.78
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 0.78
Insertion of genes into retrovirus genomes and of retrovirus DNA into cell genomes. Prog Med Virol (1985) 0.76
Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells. J Neurosci Res (1996) 0.76